JYOTI SHARMA: Open Payments
NPI 1174996870 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 39 payments from 18 companies in 2025. Trend: 2023 $699 · 2024 $861 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $221 |
| Amgen Inc. | 2 | $75 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| PFIZER INC. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $49 |
| ZOLL Respicardia, Inc. | 2 | $39 |
| Medtronic, Inc. | 1 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $31 |
Products named: LEQVIO, REPATHA, ELIQUIS, ENTRESTO, TRELEGY ELLIPTA, Kerendia, Wegovy, remede System.
Industry payments across AZ — which companies pay providers there.
